Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Therion Biologics Corporation develops therapeutic vaccines for cancer and preventive vaccines for AIDS. The Company has two lead programs involving multiple clinical trials: PANVAC-VF for pancreatic cancer and PROSTVAC® -VF for prostate cancer. Therion is also applying its technology platform to develop vaccines to treat melanoma, breast cancer and other solid tumors. In addition to studies conducted under collaboration with the National Cancer Institute, the Company’s strategic partners include a global network of leading clinical institutions and Aventis Pasteur, Ltd., which is developing ALVAC-CEA/B7.1, a clinical candidate for the treatment of colon cancer. Therion is headquartered in Cambridge, Massachusetts. ( www.therionbio.com )
Therion Biologics Corporation
76 Rogers Street
Cambridge, Massachusetts 02142-1119
USA
Tel: (617) 475-7500
Fax: (617) 475-7501